Effects of Ivabradine on Residual Myocardial Ischemia After PCI

Summary

This is a randomized pharmacological study evaluating the effects of ivabradine in patients with residual angina after PCI. The role of ivabradine in patients with angina, without systolic dysfunction, is not yet clear. The investigators performed in all patients an echostress to evaluate the effects of therapy with ivabradine after 30 days in terms of exercise tolerance and diastolic function.

Timeline

Start

2015-03-05

Primary completion

2017-03-07

Completion

2017-03-07

Drugs

Indications